long term safety of glp-1 🧠 Researchers are exploring whether medications used for #diabetes and weight loss could treat #Alzheimers and addiction, but public concerns persist about long-term safety. 🔗 Read the full article at beingpatient.com # GLP-1s 101: What the science

To understand why reviews and complaints are separated, it's essential to examine both sides in detail

Semaglutide had been approved for both diabetes and obesity treatment, while tirzepatide was only approved for obesity in November of 2023 (26, 27)

At the same time, their use in weight management is also increasing

Date: May 22, 2026 Source: Aarhus University Summary: Researchers have discovered that the GLP-1 hormone targeted by drugs like Wegovy is present in very low amounts inside the joints of arthritis patients

Failure of precise interplay of alpha- and beta-cell function is central to the pathogenesis of type 1 (T1DM) and type 2 (T2DM) diabetes mellitus

New Book Out October 6, 2026 The full system behind the guide These five days are the doorway